None listed
Conditions
Brief summary
The aim of this study is evaluate the efficacy of the Neuro Psycho Physical Optimization (NPPO) protocol treatment with Radioelectric Asymmetric Conveyer (REAC) in the improvement of the psychic and symptomatic stress-related disorders in a group of subjects revealing high values of psychological stress. These randomized, single-blinded controlled study, was conducted on subjects that voluntarily came to our Institute declaring to “feel stressed”. One hundred twenty four (124) subjects (females, n = 81, males, n = 43) with psychological distress symptoms, were recruited an randomized to REAC therapy or placebo. Eighteen sessions of NPPO protocol treatment with REAC, or placebo (inactivated REAC), was applied to seven specific points of the auricular pavilion and were administered on alternate days, lasting about four weeks. Psychological stress symptoms were assessed by Psychological Stress Measure (PSM) and Symptomatic Check List (SCL-90), pre and post intervention. Data were analyzed using the Statistical Package for Social Sciences (SPSS), version 13.0 Data conformed to a Gaussian distribution. There was a significant reduction in PSM test and SCL-90 scores in the treated group as compared to the placebo group. Results of the psychometric tests showed that the subjects that underwent the effective therapy showed a statistically relevant reduction in their level of stress and psychological disorders compared to the control placebo group.
Interventions
The intervention comprises: A cycle of auricular treatment protocol with Radioelectric Asymetric Conveyer (REAC). The REAC is a Radioelectric medical device. The protocol used, called Neuro Psycho Physical Optimization (ONPF), involves the application of a probe of the REAC on specific points of the auricular pavilion for an activation time of roughly 500 mms. The ONPF protocol is activated in a precise sequence on seven auricular points. . The protocol envisages 18 sessions of ONPF treatment lasting approximately 3,5 seconds each on alternating days, for eight (8) weeks. Assessment, at baseline and immediately at the end of treatment, with SCL-90 and Psychological Stress Measure Test
Sponsors
Study design
Eligibility
Inclusion criteria
Healthy Subjects without organic diseases, over 18 years old, who claimed to be stressed, with any type of stress-related symptoms and with Psychological stress measure test (PSM) total score over 45 points. No history of drug abuse, nor severe mental illness or personality disorder. No medications, known to affect cognitive functioning nor undergoing psychological interventions.
Exclusion criteria
Diagnosis of psychiatric pathology, organic central nervous system (CNS) pathology, preceding skull traumas with loss of conscience longer than 5 minutes, dementia, alcohol dependence, current therapy with medications known to affect cognitive functioning.